ElectroCore Inc
ECORHealthcare·Medical Devices·USA·Nano·NASD·Nov 12 • 3:59 PM ET
5.29-2.42 (-31.39%)
2026-11-13 13:23 CET
Market cap
$48.81M
Revenue, TTM
37.97 USD m
Net income, TTM
-12.70 USD m
Free cash flow, TTM
-10.90 USD m
EPS diluted, TTM
-1.43
Price
ECOR against its 20, 50 and 200-day averagesPatternshover a marker to name it
58.3% under the 52-week high of 12.70 on 22 Sep 2026. 52-week low 4.41 on 18 Dec 2025. Last 15 sessions, 82.9% high to low
Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average
Setup. RS line 14
CANSLIM 2 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%; Average Volume: Over 200K
VCP 4 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 52-Week High/Low: 0-10% below High
Minervini 1 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 3 of 4 — fails: Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%) — not on the tape: Debt/Equity: Low (<0.1); P/E: Under 25
Value 0 of 4 — fails: Return on Equity: Over +15% — not on the tape: P/E: Under 15; P/B: Under 2; Debt/Equity: Low (<0.1)
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 1 of 4 — fails: Institutional Ownership: Over 30%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K
Profile
ECOR52-week range, 11% of the way up
4.4112.70
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.
| Employees | 83 |
|---|---|
| IPO | Jun 22, 2018 |
| Beta | 1.21 |
| ATR, 14d | 1.00 |
| Rel volume | 0.00 |
| Short float | 5.80% |
| Insider own | 32.89% |
| Inst own | 13.28% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | $48.81M |
| Enterprise Value | 51.00M |
| Income | -12.70M |
| Sales | 37.97M |
| Book / share | -0.27 |
| Cash / share | 0.81 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 83 |
| IPO | Jun 22, 2018 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 1.29 |
| Price / book | - |
| Price / cash | 6.51 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 1.34 |
| Quick Ratio | 0.97 |
| Current Ratio | 1.34 |
| Debt / equity | - |
| Long-term debt / equity | - |
| Options and short | No / Yes |
Earnings
| Earnings / share | -1.43 |
|---|---|
| Earnings next year | -0.25 |
| Earnings next quarter | -0.16 |
| Earnings this year | 28.61% |
| Earnings next year | 78.99% |
| Earnings growth, 5 years | - |
| Past earnings growth | 29.44% 28.87% |
| Past sales growth | 55.06% 55.74% |
| Earnings vs last year | 20.47% |
| Sales vs last year | 27.26% |
| Earnings vs last quarter | 66.64% |
| Sales vs last quarter | 11.52% |
| Earnings | Nov 04 AMC |
| Surprise | 52.21% -11.30% |
Ownership
| Insiders own | 32.89% |
|---|---|
| Insider trades | -2.87% |
| Institutions own | 13.28% |
| Institution trades | 10.44% |
| Return on assets | -65.70% |
| Return on equity | -478.70% |
| Return on capital | -196.11% |
| Gross Margin | 86.13% |
| Operating margin | -33.15% |
| Profit Margin | -33.46% |
| 20-day average | -29.83% |
| 50-day average | -41.75% |
| 200-day average | -31.66% |
Technical
| Shares out | 9.17M |
|---|---|
| Shares floating | 6.19M |
| Short / float | 5.80% |
| Short ratio | 3.52 |
| Short interest | 0.36M |
| 52-week high | 12.70 -58.3% |
| 52-week low | 4.41 +20.0% |
| Volatility | 23.90% 13.59% |
| Average range | 1.00 |
| Strength index | 31.30 |
| Market sensitivity | 1.21 |
| Relative volume | 0.00 |
| Avg Volume | 102.01K |
| Volume | 0 |
Performance
| Perf Week | -39.89% |
|---|---|
| Perf Month | -35.49% |
| Perf Quarter | -46.94% |
| Perf Half Y | -17.73% |
| Perf YTD | 17.95% |
| Perf Year | -12.71% |
| Perf 3Y | -7.84% |
| Perf 5Y | -61.67% |
| Perf 10Y | - |
| Recommendation | 1.00 |
| Target Price | 18.24 |
| Prev Close | 5.29 |
| Price | 5.29 |
| Change % | 0.00% |
Analyst ratings
latest 7 of 7| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Aug 14, 2020 | Upgrade | BTIG Research | Neutral → Buy | $3.50 | -33.8% |
| Nov 14, 2019 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform | ||
| Sep 26, 2019 | Resumed | Cantor Fitzgerald | Neutral | $9 | +70.1% |
| May 30, 2019 | Downgrade | Cantor Fitzgerald | Overweight → Neutral | ||
| May 15, 2019 | Downgrade | BTIG Research | Buy → Neutral | ||
| May 09, 2019 | Initiated | Noble Capital Markets | Outperform | ||
| Sep 21, 2018 | Initiated | Cantor Fitzgerald | Overweight |
Peers
Mkt capInsider trading
latest 14 of 20| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Errico Thomas J. | Director | Sep 14 '26 | Buy | 9.82 | 5,000 | 49,082 | 363,904 | Sep 22 07:00 AM |
| Lev Joshua S. | CFO and Interim President | Aug 21 '26 | Option Exercise | 4.50 | 12,000 | 54,000 | 96,889 | Aug 25 05:30 PM |
| Lev Joshua S. | CFO and Interim President | Aug 24 '26 | Option Exercise | 4.50 | 5,000 | 22,500 | 89,889 | Aug 25 05:30 PM |
| Lev Joshua S. | CFO and Interim President | Aug 25 '26 | Option Exercise | 4.50 | 3,000 | 13,500 | 87,889 | Aug 25 05:30 PM |
| Lev Joshua S. | CFO and Interim President | Aug 21 '26 | Sale | 10.22 | 12,000 | 122,640 | 84,889 | Aug 25 05:30 PM |
| Lev Joshua S. | CFO and Interim President | Aug 24 '26 | Sale | 9.88 | 5,000 | 49,400 | 84,889 | Aug 25 05:30 PM |
| Lev Joshua S. | CFO and Interim President | Aug 25 '26 | Sale | 9.36 | 3,000 | 28,080 | 84,889 | Aug 25 05:30 PM |
| Errico Thomas J. | Director | Aug 13 '26 | Buy | 9.85 | 5,000 | 49,272 | 343,332 | Aug 17 06:19 AM |
| Goldberger Daniel S | Former Officer & Director | Apr 23 '26 | Sale | 6.80 | 80,000 | 544,000 | 211,471 | Jun 12 06:12 PM |
| Lev Joshua S. | CFO and Interim President | May 28 '26 | Sale | 9.00 | 6,667 | 60,003 | 84,889 | May 29 04:05 PM |
| Joshua S. Lev | Interim President and Chief Fi | May 27 '26 | Proposed Sale | 8.91 | 6,667 | 59,403 | May 27 08:40 PM | |
| PATTON THOMAS M | Director | May 22 '26 | Proposed Sale | 7.24 | 85,000 | 615,658 | May 27 01:17 PM | |
| Errico Thomas J. | Director | May 21 '26 | Buy | 5.99 | 9,992 | 59,852 | 360,071 | May 26 08:52 AM |
| Lev Joshua S. | CFO and Interim President | May 22 '26 | Sale | 6.50 | 3,000 | 19,500 | 91,556 | May 22 06:11 PM |
Held by
AUMNews
latest 14 of 200- Randomized Study of Non-Invasive Autonomic Neuromodulation for Long COVID Published Online in Neuromodulation (GlobeNewswire) -31.39%
- electroCore to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
- ElectroCore Halves Its Loss And Beats On EPS, But A Revenue Miss, Slowing Growth And A Guidance Cut Push The Story Into 2027 (Earnings Whispers) +16.18%
- electroCore Announces Third Quarter 2026 Financial Results (GlobeNewswire)
- ElectroCore Needs An 18% Sequential Jump To Prove Its Sales Overhaul Is Working (Earnings Whispers)
- electroCore to Announce Third Quarter September 30, 2026, Financial Results on Wednesday, November 4, 2026 (GlobeNewswire)
- electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN) (GlobeNewswire) +8.51%
- fMRI Study Suggests Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) Accelerates Neural Processes in Visual Skill Learning (GlobeNewswire)
- electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub (GlobeNewswire)
- electroCore to Participate at H.C. Wainwright Global Investment Conference (GlobeNewswire)
- electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers (GlobeNewswire)
- electroCore's Truvaga Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards (GlobeNewswire)
- electroCore Announces Second Quarter 2026 Financial Results (GlobeNewswire) +20.75%
- electroCore to Participate in Upcoming Investor Conferences (GlobeNewswire)
Quarterly earnings
2026Q3 EPS -0.130 beat -0.272, from -0.400 a year earlier. Sales 9.69 missed 10.92, from 8.69 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-04 16:30 | -0.130 | -0.272 | -0.130 | 9.69 | 10.92 | EPS -52.2% · sales -11.3% | vs 2025Q3, year-ago quarter · EPS -67.5% · sales +11.5% | 5 | Open -3.33% vs SPY -0.17%. Close +4.76% vs SPY -4.41% |
| 2026Q2ended 2026-06-30 | 2026-08-06 16:30 | -0.330 | -0.422 | -0.325 | 9.45 | 9.49 | EPS -21.8% · sales -0.5% | vs 2025Q2, year-ago quarter · EPS -25.0% · sales +28.0% | 5 | Open 0.00% vs SPY +0.32%. Close +20.75% vs SPY +0.61% |
| 2026Q1ended 2026-03-31 | 2026-05-06 16:30 | -0.590 | -0.612 | -0.589 | 9.58 | 9.01 | EPS -3.6% · sales +6.4% | vs 2025Q1, year-ago quarter · EPS +25.5% · sales +42.6% | 5 | Open -1.13% vs SPY +0.17%. Close -5.86% vs SPY -0.31% |
| 2025Q4ended 2025-12-31 | 2026-03-19 16:30 | -0.340 | -0.402 | -0.379 | 9.24 | 9.10 | EPS -15.4% · sales +1.5% | vs 2024Q4, year-ago quarter · EPS -8.1% · sales +31.2% | 5 | Open -2.21% vs SPY -0.50%. Close -4.65% vs SPY -1.70% |
| 2025Q3ended 2025-09-30 | 2025-11-05 16:30 | -0.400 | -0.400 | -0.403 | 8.69 | 7.89 | EPS 0.0% · sales +10.2% | vs 2024Q3, year-ago quarter · EPS +29.0% · sales +32.6% | 5 | Open +4.85% vs SPY -0.16%. Close +23.21% vs SPY -1.07% |
| 2025Q2ended 2025-06-30 | 2025-08-06 16:30 | -0.440 | -0.325 | -0.441 | 7.38 | 7.25 | EPS +35.4% · sales +1.8% | vs 2024Q2, year-ago quarter · EPS +15.8% · sales +20.2% | 4 | Open -17.60% vs SPY +0.55%. Close -29.15% vs SPY -0.08% |
| 2025Q1ended 2025-03-31 | 2025-05-07 16:30 | -0.470 | -0.483 | -0.465 | 6.72 | 6.85 | EPS -2.6% · sales -1.9% | vs 2024Q1, year-ago quarter · EPS -11.3% · sales +23.4% | 4 | Open -14.83% vs SPY +0.73%. Close -23.79% vs SPY +0.70% |
| 2024Q4ended 2024-12-31 | 2025-03-12 16:30 | -0.370 | -0.300 | -0.485 | 7.05 | 7.05 | EPS +23.3% · sales -0.1% | vs 2023Q4, year-ago quarter · EPS -39.3% · sales +35.7% | 5 | Open -9.77% vs SPY -0.07%. Close -26.54% vs SPY -1.33% |
| 2024Q3ended 2024-09-30 | 2024-11-13 16:30 | -0.310 | -0.326 | -0.309 | 6.55 | 6.71 | EPS -4.9% · sales -2.4% | vs 2023Q3, year-ago quarter · EPS -54.4% · sales +45.4% | 5 | Open -12.31% vs SPY +0.02%. Close +1.49% vs SPY -0.64% |
| 2024Q2ended 2024-06-30 | 2024-08-07 16:30 | -0.380 | -0.430 | -0.377 | 6.14 | 5.60 | EPS -11.6% · sales +9.7% | vs 2023Q2, year-ago quarter · EPS -63.1% · sales +72.9% | 5 | Open +3.77% vs SPY +1.01%. Close -1.31% vs SPY +2.31% |
| 2024Q1ended 2024-03-31 | 2024-05-08 16:30 | -0.530 | -0.588 | -0.530 | 5.44 | 4.79 | EPS -9.9% · sales +13.6% | vs 2023Q1, year-ago quarter · EPS -57.3% · sales +95.8% | 5 | Open +1.41% vs SPY +0.04%. Close -5.36% vs SPY +0.58% |
| 2023Q4ended 2023-12-31 | 2024-03-13 16:30 | -0.610 | -0.592 | -0.609 | 5.19 | 5.03 | EPS +3.0% · sales +3.1% | vs 2022Q4, year-ago quarter · EPS -50.0% · sales +102.8% | 5 | Open -3.72% vs SPY +0.19%. Close -5.58% vs SPY -0.20% |
| 2023Q3ended 2023-09-30 | 2023-11-08 16:30 | -0.680 | -0.697 | -0.678 | 4.51 | 3.77 | EPS -2.4% · sales +19.5% | vs 2022Q3, year-ago quarter · EPS -43.3% · sales +128.1% | 6 | - |
| 2023Q2ended 2023-06-30 | 2023-08-09 16:30 | -1.030 | -0.963 | -1.032 | 3.55 | 3.55 | EPS +6.9% · sales +0.0% | vs 2022Q2, year-ago quarter · EPS -14.2% · sales +64.6% | 6 | - |
| 2023Q1ended 2023-03-31 | 2023-05-03 16:30 | -1.240 | -0.996 | -1.237 | 2.78 | 2.84 | EPS +24.5% · sales -2.1% | vs 2022Q1, year-ago quarter · EPS +3.3% · sales +46.4% | 5 | - |
| 2022Q4ended 2022-12-31 | 2023-03-08 16:30 | -1.220 | -1.116 | -1.221 | 2.56 | 2.36 | EPS +9.3% · sales +8.4% | vs 2021Q4, year-ago quarter · EPS +16.2% · sales +71.7% | 5 | - |
Annual earnings
2025FY EPS -1.650 beat -1.724, from -1.590 a year earlier. Sales 32.03 beat 31.92, from 25.18 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | 2.030 | - | - | 95.77 | 2.61 |
| 2029FYestimate | - | 1.165 | - | - | 78.84 | 4.54 |
| 2028FYestimate | - | 0.463 | - | - | 66.46 | 11.44 |
| 2027FYestimate | - | -0.248 | - | - | 52.91 | - |
| 2026FYestimate | - | -1.178 | - | - | 40.04 | - |
| 2025FY | -1.650 | -1.724 | -1.650 | 32.03 | 31.92 | - |
| 2024FY | -1.590 | -1.502 | -1.588 | 25.18 | 25.19 | - |
| 2023FY | -3.420 | -3.334 | -3.415 | 16.03 | 15.87 | - |
| 2022FY | -4.690 | -4.602 | -4.687 | 8.59 | 8.38 | - |
| 2021FY | -4.350 | -4.375 | -4.364 | 5.45 | 5.48 | - |
| 2020FY | -9.000 | -8.826 | -9.043 | 3.50 | 3.47 | - |
| 2019FY | -23.100 | -22.775 | -23.050 | 2.39 | 2.66 | - |
| 2018FY | -17.850 | -25.050 | -17.789 | 0.99 | 0.90 | - |
Quarterly results
2026Q3 revenue 9.69, from 8.69 a year earlier. Operating margin -16.1%, from -33.1% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -1.18 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-05 | -1.18 | -14.4% |
| 2026Q4 | E | per share | 2026-11-05 | -0.16 | -22.3% |
| 2026FY | R | per share | 2026-11-05 | -1.26 | -11.9% |
| 2026Q4 | R | per share | 2026-11-05 | -0.24 | +4.3% |
| 2026FY | S | per share | 2026-11-05 | 40.04 | -4.5% |
| 2026Q4 | S | per share | 2026-11-05 | 11.32 | -5.3% |
| 2026Q3 | E | per share | 2026-11-04 | -0.27 | 0.0% |
| 2026Q3 | S | per share | 2026-11-04 | 10.92 | 0.0% |
| 2026Q3 | R | per share | 2026-10-21 | -0.31 | 0.0% |
| 2026Q2 | E | per share | 2026-08-07 | -0.37 | -12.0% |
| 2026Q2 | R | per share | 2026-08-07 | -0.33 | -20.7% |
| 2026Q2 | S | per share | 2026-08-07 | 9.57 | +0.8% |
| 2026Q1 | E | per share | 2026-03-20 | -0.61 | +39.1% |
| 2026Q1 | R | per share | 2026-03-20 | -0.60 | +1.7% |
| 2026Q1 | S | per share | 2026-03-20 | 9.01 | -0.7% |
| 2025Q4 | E | per share | 2026-03-11 | -0.40 | +5.8% |
| 2025FY | S | per share | 2026-03-11 | 31.92 | 0.0% |
| 2025Q4 | S | per share | 2026-03-11 | 9.10 | -0.4% |
| 2025FY | E | per share | 2026-03-06 | -1.70 | 0.0% |
| 2025FY | R | per share | 2026-01-21 | -1.77 | +4.1% |
| 2025Q4 | R | per share | 2026-01-21 | -0.46 | +17.9% |
| 2025Q3 | E | per share | 2025-10-23 | -0.40 | +4.7% |
| 2025Q3 | S | per share | 2025-10-23 | 7.89 | -0.5% |
| 2025Q3 | R | per share | 2025-10-21 | -0.41 | 0.0% |
| 2025Q2 | E | per share | 2025-07-22 | -0.33 | 0.0% |
| 2025Q2 | R | per share | 2025-07-22 | -0.33 | 0.0% |
| 2025Q2 | S | per share | 2025-07-22 | 7.25 | 0.0% |
| 2025Q1 | E | per share | 2025-03-13 | -0.48 | +103.8% |
| 2025Q1 | R | per share | 2025-03-13 | -0.39 | +62.5% |
| 2025Q1 | S | per share | 2025-03-13 | 6.85 | -13.1% |
| 2024FY | E | per share | 2025-03-07 | -1.53 | +1.7% |
| 2024Q4 | E | per share | 2025-03-07 | -0.29 | -2.5% |
| 2024FY | S | per share | 2025-03-07 | 25.12 | -0.3% |
| 2024Q4 | S | per share | 2025-03-07 | 6.97 | -1.1% |
| 2024Q4 | R | per share | 2025-03-03 | -0.29 | 0.0% |
| 2024FY | R | per share | 2024-12-18 | -1.51 | +0.0% |
| 2024Q3 | E | per share | 2024-10-29 | -0.33 | +6.9% |
| 2024Q3 | S | per share | 2024-10-29 | 6.71 | +3.3% |
| 2024Q3 | R | per share | 2024-10-22 | -0.30 | 0.0% |
| 2024Q2 | S | per share | 2024-07-29 | 5.60 | 0.0% |
| 2024Q2 | E | per share | 2024-07-23 | -0.43 | 0.0% |
| 2024Q2 | R | per share | 2024-07-23 | -0.45 | 0.0% |
| 2024Q1 | S | per share | 2024-04-03 | 4.79 | 0.0% |
| 2024Q1 | E | per share | 2024-03-14 | -0.59 | -1.2% |
| 2024Q1 | R | per share | 2024-03-14 | -0.57 | -19.7% |
| 2023FY | S | per share | 2024-01-23 | 15.87 | 0.0% |
| 2023FY | E | per share | 2024-01-19 | -3.33 | -0.6% |
| 2023FY | R | per share | 2024-01-17 | -3.58 | +0.1% |
Estimate history
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -19.031 | -17.789 | -23.05 | -9.043 | -4.364 | -4.687 | -3.415 | -1.588 | -1.646 | -1.4277 | - |
| Sales USD millions | 1 | 1 | 2 | 3 | 5 | 9 | 16 | 25 | 32 | 38 | - |
| Shares million shares | 2 | 2 | 2 | 3 | 5 | 5 | 6 | 7 | 8 | - | 9 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.309 | -0.485 | -0.465 | -0.441 | -0.403 | -0.379 | -0.589 | -0.325 | -0.135 |
| Sales USD millions | 7 | 7 | 7 | 7 | 9 | 9 | 10 | 9 | 10 |
| Shares million shares | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 9 | 9 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 37.97 | 32.03+27.2% | 25.18+57.1% | 16.03+86.6% | 8.59+57.6% | 5.45+55.7% | 3.50+46.4% | 2.39+141.4% | 0.99 |
| Cost of Goods Sold Incl. D&A | 5.27 | 4.24+11.9% | 3.79+35.4% | 2.80+72.8% | 1.62+16.5% | 1.39-20.1% | 1.74+50.0% | 1.16+100.0% | 0.58 |
| Gross Profit | 32.70 | 27.79+29.9% | 21.40+61.8% | 13.23+89.5% | 6.98+71.5% | 4.07+131.3% | 1.76+43.1% | 1.23+200.0% | 0.41 |
| Selling, General and Administrative Excl. Other | 45.28 | 40.94+22.0% | 33.56+4.8% | 32.03+7.3% | 29.85+23.5% | 24.17-7.2% | 26.04-42.5% | 45.32-17.6% | 54.97 |
| Research and Development | 2.91 | 2.73+15.7% | 2.36-55.6% | 5.32-3.6% | 5.52+117.3% | 2.54-39.5% | 4.20-57.6% | 9.90-20.6% | 12.47 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -12.59 | -13.15 | -12.16 | -18.80 | -22.87 | -20.10 | -24.28 | -44.09 | -54.55 |
| Interest Expense | 1.33 | 0.59 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.01 | - | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.00-100.0% | 0.46 | 0.00 | -1.48-421.7% | 0.46-77.0% | 2.00+7.0% | 1.87 |
| Net Income Before Taxes | -13.10 | -13.96 | -11.98 | -19.02 | -22.59 | -18.07 | -24.68 | -45.13 | -55.76 |
| Income Taxes | -0.40 | 0.00 | -0.09 | -0.19 | -0.43 | -0.85 | -1.17-5950.0% | 0.02 | 0.00 |
| Consolidated Net Income | -12.70 | -13.97 | -11.89 | -18.83 | -22.16 | -17.22 | -23.51 | -45.15 | -55.77 |
| Net Income From Continuing Operations | -12.70 | -13.97 | -11.89 | -18.83 | -22.16 | -17.22 | -23.51 | -45.15 | -34.70 |
| Net Income | -12.70 | -13.97 | -11.89 | -18.83 | -22.16 | -17.22 | -23.51 | -45.15 | -34.70 |
| EPS (Recurring) per share | -1.28 | -1.65 | -1.59 | -3.36 | -4.69 | -4.63 | -8.92 | -22.34 | -17.12 |
| EPS (Basic, Before Extraordinaries) per share | -1.43 | -1.65 | -1.59 | -3.42 | -4.69 | -4.36 | -9.04 | -23.05 | -17.79 |
| EPS (Diluted) per share | -1.43 | -1.65 | -1.59 | -3.42 | -4.69 | -4.36 | -9.04 | -23.05 | -17.79 |
| EBITDA | -11.30 | -11.48 | -10.90 | -17.55 | -22.28 | -19.66 | -23.79 | -43.78 | -54.49 |
| Non-Operating Income (Expense) | 0.82 | -0.22-222.2% | 0.18-28.0% | 0.25-10.7% | 0.28-49.1% | 0.55+685.7% | 0.07-92.7% | 0.96+45.5% | 0.66 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 2.43 | 1.52+2.7% | 1.48+10.4% | 1.34-36.8% | 2.12-12.0% | 2.41+1.3% | 2.38-16.2% | 2.84-52.7% | 6.00 |
| Price To Sales Ratio ratio | 2.84 | 1.19 | 4.82 | 2.05 | 2.12 | 6.32 | 17.40 | 19.54 | 184.48 |
| Gross Margin % | 86.13 | 86.75 | 84.97 | 82.51 | 81.19 | 74.59 | 50.30 | 51.60 | 41.71 |
| Operating Margin % | -33.15 | -41.06 | -48.30 | -117.31 | -266.22 | -368.74 | -694.65 | -1,844.61 | -5,494.07 |
| Net Margin % | -33.46 | -43.60 | -47.20 | -117.49 | -257.94 | -315.86 | -672.55 | -1,888.81 | -3,494.84 |
| Shares Outstanding million shares | 9.17 | 8.00+20.3% | 6.65+10.8% | 6.00+26.6% | 4.74+0.6% | 4.71+54.9% | 3.04+52.8% | 1.99+1.5% | 1.96 |
| Market Capitalization | 48.81 | 48.81-54.7% | 107.81+202.0% | 35.70+95.5% | 18.26-55.6% | 41.14-42.1% | 71.00+49.8% | 47.39-74.3% | 184.17 |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 9.69+11.5% | 9.45+28.0% | 9.58+42.6% | 9.24+31.1% | 8.69+32.7% | 7.38+20.2% | 6.72+23.5% | 7.05+35.8% |
| Cost of Goods Sold Incl. D&A | 1.12-8.2% | 1.27+35.1% | 1.22+20.8% | 1.66+67.7% | 1.22+15.1% | 0.94+11.9% | 1.01+13.5% | 0.99-10.0% |
| Gross Profit | 8.57+14.7% | 8.18+27.0% | 8.36+46.4% | 7.59+25.5% | 7.47+36.1% | 6.44+21.5% | 5.71+25.5% | 6.05+47.9% |
| Selling, General and Administrative Excl. Other | 10.13-2.1% | 10.95+10.1% | 13.68+43.5% | 10.53+15.5% | 10.35+27.1% | 9.95+26.1% | 9.53+13.5% | 9.12+13.6% |
| Research and Development | 0.43-34.8% | 0.82+60.8% | 0.74+15.6% | 0.92+13.6% | 0.66+26.9% | 0.51-20.3% | 0.64+60.0% | 0.81-27.0% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -1.56 | -2.77 | -5.32 | -2.94 | -2.88 | -3.51 | -3.82 | -3.07 |
| Interest Expense | 0.37+76.2% | 0.32 | 0.32 | 0.32 | 0.21 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 0.40 | 0.00 | 0.00 | 0.00-100.0% |
| Net Income Before Taxes | -1.47 | -3.06 | -5.59 | -2.98 | -3.40 | -3.67 | -3.90 | -3.20 |
| Income Taxes | -0.13 | 0.00 | -0.32 | 0.05+66.7% | 0.00 | 0.00 | -0.05 | 0.030.0% |
| Consolidated Net Income | -1.34 | -3.06 | -5.27 | -3.04 | -3.40 | -3.67 | -3.85 | -3.23 |
| Net Income From Continuing Operations | -1.34 | -3.06 | -5.27 | -3.04 | -3.40 | -3.67 | -3.85 | -3.23 |
| Net Income | -1.34 | -3.06 | -5.27 | -3.04 | -3.40 | -3.67 | -3.85 | -3.23 |
| EPS (Recurring) per share | -0.13 | -0.33 | -0.59 | -0.38 | -0.37 | -0.44 | -0.47 | -0.49 |
| EPS (Basic, Before Extraordinaries) per share | -0.13 | -0.33 | -0.59 | -0.38 | -0.40 | -0.44 | -0.47 | -0.49 |
| EPS (Diluted) per share | -0.13 | -0.33 | -0.59 | -0.38 | -0.40 | -0.44 | -0.47 | -0.49 |
| EBITDA | -1.52 | -2.74 | -5.27 | -1.77 | -2.73 | -3.35 | -3.63 | -2.49 |
| Non-Operating Income (Expense) | 0.46+411.1% | 0.03 | 0.04 | 0.28 | 0.09-40.0% | -0.17 | -0.08-136.4% | -0.13 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 0.49+19.5% | 0.76+90.0% | 0.82+90.7% | 0.37-9.8% | 0.41+28.1% | 0.40+8.1% | 0.43+13.2% | 0.41+2.5% |
| Price To Sales Ratio ratio | 2.84 | 2.20 | 1.55 | 1.12 | 1.40 | 1.59 | 2.10 | 4.28 |
| Gross Margin % | 88.47 | 86.53 | 87.27 | 82.07 | 85.97 | 87.28 | 84.92 | 85.89 |
| Operating Margin % | -16.06 | -29.33 | -55.47 | -31.82 | -33.19 | -47.50 | -56.88 | -43.59 |
| Net Margin % | -13.82 | -32.37 | -55.00 | -32.84 | -39.19 | -49.74 | -57.37 | -45.81 |
| Shares Outstanding million shares | 9.17+20.0% | 9.00+20.5% | 8.13+9.6% | 8.00+20.3% | 7.64+17.4% | 7.47+15.8% | 7.42+23.5% | 6.65+10.8% |
| Market Capitalization | 48.81+30.0% | 71.67+82.9% | 48.74-1.8% | 35.86-66.7% | 37.54-20.1% | 39.18+1.5% | 49.64+34.0% | 107.81+202.0% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 | 2017FY12/31/2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 11.61-5.0% | 12.22+15.5% | 10.58-41.1% | 17.96-48.2% | 34.69+53.3% | 22.63-5.9% | 24.06-64.9% | 68.56+84.4% | 37.17 |
| Short Term Receivables | 1.03-24.8% | 1.37+90.3% | 0.72+80.0% | 0.40-9.1% | 0.44+63.0% | 0.27-46.0% | 0.50+85.2% | 0.27+170.0% | 0.10 |
| Inventories | 1.63-3.0% | 1.68-22.2% | 2.16+9.1% | 1.98+45.6% | 1.36+54.5% | 0.88-1.1% | 0.89-54.4% | 1.95+490.9% | 0.33 |
| Other Current Assets | 1.40+34.6% | 1.04+23.8% | 0.84+1.2% | 0.83-21.0% | 1.05-18.6% | 1.29+18.3% | 1.09-43.2% | 1.92+236.8% | 0.57 |
| Total Current Assets | 15.67-3.9% | 16.30+14.1% | 14.29-32.5% | 21.17-43.6% | 37.54+49.8% | 25.06-5.5% | 26.53-63.5% | 72.70+90.4% | 38.18 |
| Net Property, Plant & Equipment | 2.95-24.4% | 3.90+449.3% | 0.71+16.4% | 0.61-19.7% | 0.760.0% | 0.76-57.3% | 1.78+368.4% | 0.38+123.5% | 0.17 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | - | - | - | - | - | - | - | 0.00 | 0.00 |
| Deferred Tax Assets | 0.89-22.6% | 1.15+310.7% | 0.28-9.7% | 0.31-22.5% | 0.40 | - | 0.62 | - | - |
| Other Assets | 0.05-81.5% | 0.27-75.5% | 1.10-63.0% | 2.97-34.4% | 4.53-20.4% | 5.69-20.4% | 7.15+1602.4% | 0.42-52.8% | 0.89 |
| Total Assets | 19.56-9.5% | 21.62+31.9% | 16.39-34.6% | 25.06-42.0% | 43.23+37.2% | 31.52-12.7% | 36.09-50.9% | 73.50+87.4% | 39.23 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.38+5.6% | 0.36+300.0% | 0.09+28.6% | 0.07+16.7% | 0.06-94.1% | 1.01+68.3% | 0.60 | 0.00 | 0.00 |
| Accounts Payable | 2.71+48.1% | 1.83-15.3% | 2.16+1.4% | 2.13+38.3% | 1.54-26.0% | 2.08-60.1% | 5.21+93.0% | 2.70+221.4% | 0.84 |
| Income Tax Payable | - | - | 0.27 | - | - | - | - | - | - |
| Other Current Liabilities | 8.26+18.7% | 6.96+24.3% | 5.60+15.7% | 4.84+24.7% | 3.88+38.6% | 2.80-16.2% | 3.34-23.6% | 4.37-17.2% | 5.28 |
| Total Current Liabilities | 11.35+24.0% | 9.15+12.7% | 8.12+15.3% | 7.04+28.2% | 5.49-6.8% | 5.89-35.6% | 9.14+29.3% | 7.07+15.5% | 6.12 |
| Long Term Debt | 9.03+139.5% | 3.77+598.1% | 0.54-12.9% | 0.62-11.4% | 0.70-64.6% | 1.98+39.4% | 1.42 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 0.89-22.6% | 1.15+310.7% | 0.28-9.7% | 0.31-22.5% | 0.40 | - | 0.62 | - | - |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.25-19.4% | 0.31 |
| Total Liabilities | 21.27+51.2% | 14.07+57.2% | 8.95+12.2% | 7.98+21.1% | 6.59-16.3% | 7.87-29.7% | 11.19+52.9% | 7.32+13.8% | 6.43 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 122.27 |
| Common Equity | -1.71-122.7% | 7.54+1.3% | 7.44-56.5% | 17.09-53.4% | 36.65+59.3% | 23.01-5.2% | 24.26-63.0% | 65.55 | -90.07 |
| Total Shareholders Equity | -1.71-122.7% | 7.54+1.3% | 7.44-56.5% | 17.09-53.4% | 36.65+59.3% | 23.01-5.2% | 24.26-63.0% | 65.55+103.6% | 32.20 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.640.0% | 0.640.0% | 0.64+6.7% | 0.60 |
| Total Equity | -1.71-122.7% | 7.54+1.3% | 7.44-56.5% | 17.09-53.4% | 36.65+55.0% | 23.64-5.1% | 24.90-62.4% | 66.19+101.7% | 32.81 |
| Total Liabilities & Stockholders Equity | 19.56-9.5% | 21.62+31.9% | 16.39-34.6% | 25.06-42.0% | 43.23+37.2% | 31.52-12.7% | 36.09-50.9% | 73.50+87.4% | 39.23 |
| Book Value Per Share per share | -0.21-118.6% | 1.13-8.9% | 1.24-65.6% | 3.60-53.7% | 7.77+2.5% | 7.58-37.9% | 12.20-63.5% | 33.39 | -47.89 |
| Tangible Book Value Per Share per share | -0.21-118.6% | 1.13-8.9% | 1.24-65.6% | 3.60-53.7% | 7.77+2.5% | 7.58-37.9% | 12.20-63.5% | 33.39 | -47.89 |
| Full-Time Employees people | 83+13.7% | 73+7.4% | 68+9.7% | 62+19.2% | 52+15.6% | 45-11.8% | 51-44.0% | 91+89.6% | 48 |
| Price to Book Ratio ratio | -19.35 | 14.29 | 3.23 | 0.82 | 1.12 | 3.09 | 1.95 | 2.81 | 2.10 |
| Return on Assets % | -67.84 | -62.55 | -90.88 | -64.90 | -46.07 | -69.55 | -82.39 | -61.56 | -179.61 |
| Return on Equity % | -478.70 | -158.63 | -153.57 | -82.49 | -57.72 | -99.47 | -100.54 | -71.00 | -294.99 |
| Return on Invested Capital % | -190.82 | -105.01 | -236.04 | -125.13 | -46.10 | -94.07 | -175.80 | -52.94 | -111.15 |
| Quick Ratio ratio | 1.24 | 1.60 | 1.49 | 2.72 | 6.60 | 4.11 | 2.80 | 10.00 | 6.19 |
| Current Ratio ratio | 1.38 | 1.78 | 1.76 | 3.01 | 6.84 | 4.26 | 2.90 | 10.28 | 6.24 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -12.70 | -13.97 | -11.89 | -18.83 | -22.16 | -17.22 | -23.51 | -45.15 | -55.77 |
| Depreciation | 1.28 | 1.68+33.3% | 1.26+23.5% | 1.02+70.0% | 0.60+36.4% | 0.44-42.9% | 0.77+148.4% | 0.31+342.9% | 0.07 |
| Other Funds (Non Cash) | 3.02 | 2.78+44.8% | 1.92-17.6% | 2.33-19.1% | 2.88+88.2% | 1.53-65.6% | 4.45+90.2% | 2.34-73.6% | 8.88 |
| Funds from Operations | -8.40 | -9.51 | -8.71 | -15.48 | -18.69 | -15.26 | -18.29 | -42.50 | -46.82 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -2.49 | 1.32-25.0% | 1.76+117.3% | 0.81-60.3% | 2.04+25.2% | 1.63 | -1.81 | -2.57 | -0.29 |
| Cash from Operating Activities | -10.89 | -8.19 | -6.95 | -14.67 | -16.64 | -13.63 | -20.10 | -45.07 | -47.11 |
| Capital Expenditures | -0.01 | -0.07 | 0.00 | -0.21 | 0.00 | 0.00 | 0.00 | -0.07 | -0.28 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 3.90 | 3.94 | -8.52 | 0.00 | 0.00-100.0% | 18.22 | -7.96-115.6% | 51.04 | -36.55 |
| Purchase of Investments | 0.00 | 0.00 | -8.52 | 0.00 | 0.00 | -5.08 | -24.46 | -37.22 | -81.06 |
| Sale Or Maturity of Investments | 3.90 | 3.94 | 0.00 | 0.00 | 0.00-100.0% | 23.30+41.2% | 16.50-81.3% | 88.27+98.3% | 44.51 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 3.89 | 3.88 | -8.52 | -0.21 | 0.00-100.0% | 18.22 | -7.96-115.6% | 50.97 | -36.83 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 5.22 | 0.22-97.5% | 8.67+6.5% | 8.14 | 0.00-100.0% | 25.68+46.8% | 17.49+34880.0% | 0.05-99.9% | 78.33 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 5.22 | 0.22-97.5% | 8.67+6.5% | 8.14 | 0.00-100.0% | 25.68+46.8% | 17.49+34880.0% | 0.05-99.9% | 78.33 |
| Proceedsfrom Stock Options | 3.91 | 0.12 | 0.00-100.0% | 8.14 | 0.00-100.0% | 25.68+46.8% | 17.49 | 0.00-100.0% | 78.33 |
| Issuance or Reduction of Debt, Net | 0.00 | 7.41 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 1.46+1227.3% | 0.11 | 0.00 |
| Change in Long Term Debt | 0.00 | 7.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 7.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | -0.23 | -0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | -0.23 | -0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 5.22 | 7.63-9.6% | 8.44+12.7% | 7.49 | 0.00-100.0% | 25.68+35.5% | 18.95+11743.8% | 0.16-99.8% | 78.33 |
| Exchange Rate Effect | -0.02 | 0.02-86.7% | 0.15+1400.0% | 0.01 | -0.08-144.4% | 0.18 | -0.21 | -0.10 | -0.02 |
| Net Change in Cash | -1.80 | 3.33 | -6.88 | -7.38 | -16.73-154.9% | 30.45 | -9.32-256.4% | 5.96 | -5.62 |
| Free Cash Flow | -10.90 | -8.25 | -6.95 | -14.87 | -16.64 | -13.63 | -20.10 | -45.14 | -47.39 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 7.50-43.2% | 10.04+35.9% | 8.83+10.2% | 11.61-5.0% | 13.200.0% | 7.39-49.0% | 8.01-1.1% | 12.22+15.5% |
| Short Term Receivables | 1.62+9.5% | 0.91+12.3% | 0.87-40.4% | 1.03-24.8% | 1.48+169.1% | 0.81+50.0% | 1.46+210.6% | 1.37+90.3% |
| Inventories | 3.96+227.3% | 2.42+69.2% | 1.98+14.5% | 1.63-3.0% | 1.21-38.3% | 1.43-44.6% | 1.73-31.1% | 1.68-22.2% |
| Other Current Assets | 1.37-6.2% | 0.75-18.5% | 0.85+10.4% | 1.40+34.6% | 1.46+36.4% | 0.92+155.6% | 0.77+22.2% | 1.04+23.8% |
| Total Current Assets | 14.45-16.7% | 14.12+33.7% | 12.53+4.7% | 15.67-3.9% | 17.35+3.4% | 10.56-41.2% | 11.97+2.2% | 16.30+14.1% |
| Net Property, Plant & Equipment | 2.76-27.7% | 2.89-25.1% | 2.90-25.3% | 2.95-24.4% | 3.82-2.1% | 3.86-2.5% | 3.88+124.3% | 3.90+449.3% |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | - | - | - | 0.89-22.6% | - | - | - | 1.15+310.7% |
| Other Assets | 0.05-79.2% | 0.05-64.3% | 0.05-73.7% | 0.05-81.5% | 0.24-33.3% | 0.14-68.2% | 0.19-57.8% | 0.27-75.5% |
| Total Assets | 17.26-19.4% | 17.06+17.2% | 15.48-3.5% | 19.56-9.5% | 21.41+1.7% | 14.56-34.9% | 16.04+15.5% | 21.62+31.9% |
| Short Term Debt Incl. Current Port. of LT Debt | 0.70+48.9% | 1.38+236.6% | 0.63+75.0% | 0.38+5.6% | 0.47+30.6% | 0.41+20.6% | 0.36+300.0% | 0.36+300.0% |
| Accounts Payable | 3.44+12.1% | 2.18-15.2% | 2.17+23.3% | 2.71+48.1% | 3.07+147.6% | 2.57+76.0% | 1.76-24.1% | 1.83-15.3% |
| Other Current Liabilities | 6.64-22.9% | 8.11+22.0% | 9.51+66.0% | 8.26+18.7% | 8.61+36.5% | 6.65+22.0% | 5.73+5.9% | 6.96+24.3% |
| Total Current Liabilities | 10.78-11.2% | 11.67+21.3% | 12.31+56.6% | 11.35+24.0% | 12.14+53.5% | 9.62+32.7% | 7.86+0.4% | 9.15+12.7% |
| Long Term Debt | 8.99-13.1% | 8.18+113.6% | 8.86+131.9% | 9.03+139.5% | 10.34+181.0% | 3.83+5.5% | 3.82+143.3% | 3.77+598.1% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | - | - | - | 0.89-22.6% | - | - | - | 1.15+310.7% |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 19.77-12.1% | 19.85+47.6% | 21.17+81.3% | 21.27+51.2% | 22.48+94.0% | 13.45+23.6% | 11.68+24.4% | 14.07+57.2% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | -2.51 | -2.79-351.4% | -5.69-230.2% | -1.71-122.7% | -1.07-111.3% | 1.11-90.3% | 4.37-2.9% | 7.54+1.3% |
| Total Shareholders Equity | -2.51 | -2.79-351.4% | -5.69-230.2% | -1.71-122.7% | -1.07-111.3% | 1.11-90.3% | 4.37-2.9% | 7.54+1.3% |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | -2.51 | -2.79-351.4% | -5.69-230.2% | -1.71-122.7% | -1.07-111.3% | 1.11-90.3% | 4.37-2.9% | 7.54+1.3% |
| Total Liabilities & Stockholders Equity | 17.26-19.4% | 17.06+17.2% | 15.48-3.5% | 19.56-9.5% | 21.41+1.7% | 14.56-34.9% | 16.04+15.5% | 21.62+31.9% |
| Book Value Per Share per share | -0.27 | -0.31-306.7% | -0.70-218.6% | -0.21-118.6% | -0.14-109.7% | 0.15-91.6% | 0.59-21.3% | 1.13-8.9% |
| Tangible Book Value Per Share per share | -0.27 | -0.31-306.7% | -0.70-218.6% | -0.21-118.6% | -0.14-109.7% | 0.15-91.6% | 0.59-21.3% | 1.13-8.9% |
| Full-Time Employees people | - | - | - | 83+13.7% | - | - | - | 73+7.4% |
| Price to Book Ratio ratio | -19.35 | -12.34 | -28.24 | -31.91 | 33.21 | 8.98 | 11.37 | 14.29 |
| Return on Assets % | -65.70 | -93.41 | -97.59 | -67.84 | -66.70 | -71.79 | -81.75 | -62.55 |
| Return on Equity % | - | - | - | -478.70 | -337.84 | -210.58 | -276.15 | -158.63 |
| Return on Invested Capital % | -20.67 | -56.75 | -166.33 | -41.47 | -36.73 | -74.30 | -47.10 | -28.52 |
| Quick Ratio ratio | 0.97 | 1.00 | 0.86 | 1.24 | 1.33 | 0.95 | 1.30 | 1.60 |
| Current Ratio ratio | 1.34 | 1.21 | 1.02 | 1.38 | 1.43 | 1.10 | 1.52 | 1.78 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1.34 | -3.06 | -5.27 | -3.04 | -3.40 | -3.67 | -3.85 | -3.23 |
| Depreciation | 0.03-80.0% | 0.03-81.3% | 0.05-73.7% | 1.17+101.7% | 0.15-34.8% | 0.16-30.4% | 0.19-13.6% | 0.58+141.7% |
| Other Funds (Non Cash) | 0.52-1.9% | 0.94-20.3% | 1.15+74.2% | 0.41-26.8% | 0.53+32.5% | 1.18+151.1% | 0.66+37.5% | 0.56-22.2% |
| Funds from Operations | -0.79 | -2.09 | -4.07 | -1.45 | -2.72 | -2.34 | -3.00 | -2.08 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -2.04-294.3% | -1.43-183.6% | 1.07 | -0.09-110.8% | 1.05+105.9% | 1.71+850.0% | -1.35-662.5% | 0.83 |
| Cash from Operating Activities | -2.83 | -3.52 | -3.01 | -1.54 | -1.67 | -0.62 | -4.36 | -1.25 |
| Capital Expenditures | 0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.03 | -0.04 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.35 | 2.43+1057.1% | 0.60-86.8% | 0.52 | -1.32 | 0.21 | 4.54 | -0.50 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.50 |
| Sale Or Maturity of Investments | 0.35 | 2.43+1057.1% | 0.60-86.8% | 0.52 | -1.32 | 0.21 | 4.54 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 0.35 | 2.43+1250.0% | 0.60-86.7% | 0.52 | -1.33 | 0.18 | 4.50 | -0.50 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.29 | 4.74+11750.0% | 0.23+4.5% | -0.04-110.8% | -0.00 | 0.04-99.5% | 0.22 | 0.37 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.29 | 4.74+11750.0% | 0.23+4.5% | -0.04-110.8% | -0.00 | 0.04-99.5% | 0.22 | 0.37 |
| Proceedsfrom Stock Options | 0.08-50.0% | 3.87 | 0.00 | -0.04 | 0.16 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 7.41 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 7.41 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 7.41 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 0.08 | -0.04 | -0.04 | 0.00 |
| Other Financing Activities Uses | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 0.08 | -0.04 | -0.04 | 0.00 |
| Cash from Financing Activities | 0.29-96.1% | 4.74 | 0.23+27.8% | -0.04-110.8% | 7.48 | 0.00-100.0% | 0.18 | 0.37 |
| Exchange Rate Effect | -0.00 | -0.01-133.3% | -0.00 | -0.01 | -0.01-107.7% | 0.030.0% | 0.00-100.0% | -0.09-325.0% |
| Net Change in Cash | -2.19-148.9% | 3.65 | -2.18-760.6% | -1.07 | 4.48 | -0.40-116.3% | 0.33 | -1.48 |
| Free Cash Flow | -2.83 | -3.52 | -3.01 | -1.54 | -1.67 | -0.65 | -4.39 | -1.25 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| License | 0.07 | 0.07 | 0.0% | 0.2% |
| Product | 25.12 | 31.97 | +27.3% | 99.8% |
| Total | 25.18 | 32.03 | +27.2% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Japan | 0.07 | 0.07 | 0.0% | 0.2% |
| Other Countries | 0.12 | 0.20 | +65.5% | 0.6% |
| United Kingdom | 1.67 | 1.70 | +1.7% | 5.3% |
| United States | 23.33 | 30.08 | +28.9% | 93.9% |
| Total | 25.18 | 32.03 | +27.2% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 5.80% | 0.4M | 6.2M | 87.42K |
| 2026-10-15 | 5.75% | 0.3M | 6.1M | 83.68K |
| 2026-09-30 | 5.19% | 0.3M | 6.1M | 88.12K |
| 2026-09-15 | 5.32% | 0.3M | 6.1M | 84.74K |
| 2026-08-31 | 5.29% | 0.3M | 6.2M | 101.70K |
| 2026-08-14 | 5.23% | 0.3M | 6.2M | 119.26K |
| 2026-07-31 | 5.86% | 0.4M | 6.0M | 109.82K |
| 2026-07-15 | 6.51% | 0.4M | 5.7M | 109.79K |
| 2026-06-30 | 3.93% | 0.2M | 5.2M | 106.65K |
| 2026-06-15 | 3.98% | 0.2M | 5.2M | 104.53K |
| 2026-05-29 | 5.56% | 0.3M | 5.0M | 85.98K |
| 2026-05-15 | 5.66% | 0.3M | 5.1M | 65.24K |
| 2026-04-30 | 6.54% | 0.3M | 5.1M | 59.50K |
| 2026-04-15 | 6.72% | 0.3M | 5.1M | 70.47K |
| 2026-03-31 | 5.74% | 0.3M | 5.1M | 68.55K |
| 2026-03-13 | 5.16% | 0.3M | 5.1M | 64.24K |
| 2026-02-27 | 5.20% | 0.3M | 5.0M | 59.82K |
| 2026-02-13 | 5.26% | 0.3M | 5.0M | 57.43K |
| 2026-01-30 | 5.37% | 0.3M | 5.0M | 70.81K |
| 2026-01-15 | 5.47% | 0.3M | 5.1M | 59.25K |
Option chain
expiry 2026-11-13| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-04 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-04 | 8-K | Current report | 2026-11-04 | SEC |
| 2026-09-22 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-14 | SEC |
| 2026-09-18 | 4/A | 2026-09-11 | SEC | |
| 2026-09-14 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-11 | SEC |
| 2026-09-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-09 | SEC |
| 2026-09-09 | 8-K | Current report | 2026-09-08 | SEC |
| 2026-08-25 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-21 | SEC |
| 2026-08-17 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-13 | SEC |
| 2026-08-13 | SCHEDULE 13G/A | SEC | ||
| 2026-08-06 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-08-06 | 8-K | Current report | 2026-08-06 | SEC |
| 2026-07-20 | DEF 14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | 2026-07-20 | SEC |
| 2026-06-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-04-23 | SEC |
| 2026-05-29 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-28 | SEC |
| 2026-05-27 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-05-27 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-05-26 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-20 | SEC |
| 2026-05-22 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-22 | SEC |
| 2026-05-14 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-05-06 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-03-31 | SEC |
| 2026-05-06 | 8-K | Current report | 2026-05-06 | SEC |
| 2026-05-05 | SCHEDULE 13G | SEC | ||
| 2026-05-05 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-04-23 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-04-15 | D | Notice of sales of securities on Form D (Regulation D) | SEC | |
| 2026-04-14 | 4 | Statement of changes in beneficial ownership of securities | 2026-04-13 | SEC |
| 2026-04-14 | 4 | Statement of changes in beneficial ownership of securities | 2026-04-10 | SEC |
| 2026-04-14 | 3 | Initial statement of beneficial ownership of securities | 2026-04-13 | SEC |
| 2026-04-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-04-01 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 49.08K | 1 | 0 | 0 |
| 2026-08 | 49.27K | 1 | 200.12K | 3 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 59.85K | 1 | 79.50K | 2 |
| 2026-04 | 0 | 0 | 640.75K | 2 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 4.84K | 1 | 12.63K | 1 |
| 2025-11 | 0 | 0 | 13.39K | 1 |
Institutional holders
| Manager | % owned |
|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 2.55% |
| FourWorld Capital Management LLC | 1.13% |
| WEXFORD CAPITAL LP | 1.11% |
| NORTHERN TRUST CORP | 0.80% |
| GEODE CAPITAL MANAGEMENT, LLC | 0.76% |
| Jaffetilchin Investment Partners, LLC | 0.72% |
| Wealthspire Advisors, LLC | 0.57% |
| CITADEL ADVISORS LLC | 0.53% |
| MARSHALL WACE, LLP | 0.53% |
| VANGUARD FIDUCIARY TRUST CO | 0.47% |
Funds
| Fund | % owned |
|---|---|
| Avantis International Small Cap Value ETF | 11.74% |
| Avantis International Equity ETF | 4.30% |
| Federated Hermes SDG Engagement Equity Fund | 1.84% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 1.70% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.74% |
| Fidelity Extended Market Index Fund | 0.36% |
| Ultra-Small Company Fund | 0.30% |
| Avantis International Small Cap Equity ETF | 0.29% |
| Avantis International Equity Fund | 0.27% |
| Avantis International Small Cap Value Fund | 0.22% |
OakChart. ECOR. Cached 15 minutes. Terms